Biodegradable multilayer constructs
View Patent ↗Embodiments of the present invention relate generally to the field of tissue repair and regeneration. More specifically embodiments of present disclosure relate to devices or constructs and methods to prepare various devices or constructs useful in directing cellular repair and controlling tissue regeneration to prevent or minimize postsurgical or post traumatic adhesions, excessive scars and/or fibrotic reactions of injured tissues.
1. An implantable multilayer construct promoting repair and regeneration of a wounded or defective tissue, preventing an adhesion to surrounding tissue, and preventing excessive fibrotic reaction of the injured tissue and comprising: at least two fibrillar nanoweave biopolymer layers attached by intermediate biodegradable layer where the intermediate layer has a rate of degradation higher than at least one nanoweave biopolymer layer under physiological conditions.
2. The multilayer construct according to claim 1 , wherein the at least two fibrillar nanoweave biopolymer layers enables cell guidance and tissue regeneration.
3. The multilayer construct according to claim 1 wherein the at least two fibrillar nanoweave biopolymer layers stimulates non-scarring phenotype for adherent cells.
4. The multilayer construct according to claim 1 wherein the at least two fibrillar nanoweave biopolymer layers is made from collagen.
5. The multilayer construct according to claim 1 wherein the at least two fibrillar nanoweave biopolymer layers is comprised of oriented fibrillar biopolymer material.
6. The multilayer construct according to claim 1 wherein one of the fibrillar nanoweave biopolymer layers has no pores with diameter greater than 0.5 micron.
7. The multilayer construct according to claim 1 or claim 6 further comprising a biopolymer layer with the pore diameter in a range 10-500 micrometers that permit repair cells to infiltrate said layer.
8. The multilayer construct according to claim 1 wherein the intermediate layer has a gradient degradation rate with slow degradation at the surface of fibrillar nanoweave biopolymer layers and the highest degradation in the median plane between nanoweave biopolymer layers such that the degradation is separating multilayer construct to at least two parts with low friction and low tissue adhesion between them.
9. The multilayer construct according to claim 1 where the intermediate layer comprises a biologically active agent being arranged to be released by the construct through a period of desired duration.
10. The multilayer construct according to claim 9 wherein the biologically active agent is effective in preventing tissue adhesions.
11. The multilayer construct according to claim 1 which has diffusive transmittance in the visible spectrum more than 20%.
12. The multilayer construct according to claim 1 further comprising at least one planar network of nanowires.
13. The multilayer construct according to claim 12 where the nanowires selected from one or more of: metal nanowires, or plastic nanowires, or piezoelectric nanowires, or the combination thereof.
14. The multilayer construct according to claim 12 wherein the nanowires form a planar array of cells or coils.
15. The multilayer construct according to the claim 12 or claim 14 where an external alternating magnetic excitation field applied to the construct after implantation of the construct into a mammal body is coupled to the planar nanowire network to monitor changes of the complex conductivity and changes of the relative magnetic permeability in the region of the planar nanowire network by suitable external receiver coils measuring a field perturbation due to the induction of Eddy currents and magnetic dipoles between the network cells.
16. The multilayer construct according to claim 12 where, after implantation of the construct into a mammal body, the network deformation under different mammal body positions is measured by a suitable x-ray stereotactic device and used to estimate post surgical or post-traumatic adhesion.
17. The multilayer construct according to claim 12 wherein an external alternating magnetic excitation field applied to the construct after implantation of the construct into a mammal body is coupled to the planar nanowire network to enhance tissue repair and regeneration and to reduce pain.
18. The multilayer construct according to claim 1 where intermediate biodegradable layer comprises electrically conductive layer.
19. The multilayer construct according to claim 1 or claim 18 further comprising: conductive layer serving as biocompatible biodegradable antibacterial electrode and scaffold for neuromuscular electromagnetic stimulation, electromagnetic stimulation for tissue repair, pain management with electromagnetic stimulation, and for transdermal drug delivery.
20. The multilayer construct according to the claim 18 wherein the electrically conductive layer triggers and controls the separation under external pulsed electromagnetic field.
21. The multilayer construct according to claim 1 which has at least one layer comprising hyaluronic acid, chondroitin 6-sulphate, keratin sulphate, dermatan sulphate, PEG, laminin, albumin, alginate, heparin, polyacrylic acids, polymethacrylic acid, polyethylene amine, polysaccharides, alginic acid, pectinic acids, carboxy methyl cellulose, chitosan, carboxymethyl chitosan, carboxymethyl starch, carboxymethyl dextran, heparin sulfate.
22. The multilayer construct according to claim 1 which has one surface promoting adhesion to tissue and the other surface inhibits adhesion to tissue under physiological conditions and act as a barrier to prevent passage of cells there through.
23. A multilayer construct according to claim 1 promoting repair and regeneration of a damaged or wounded area of patient's spinal cord and preventing an adhesion to surrounding tissue and excessive fibrotic reaction of the injured tissue.
24. The multilayer construct according to the claim 1 further comprising at least one layer which has laser diffraction pattern with at least one elongated branch.